FI962841A0 - Makrokapseloituja erittäviä soluja - Google Patents

Makrokapseloituja erittäviä soluja

Info

Publication number
FI962841A0
FI962841A0 FI962841A FI962841A FI962841A0 FI 962841 A0 FI962841 A0 FI 962841A0 FI 962841 A FI962841 A FI 962841A FI 962841 A FI962841 A FI 962841A FI 962841 A0 FI962841 A0 FI 962841A0
Authority
FI
Finland
Prior art keywords
secretory cells
agarose
macroencapsulated
macroencapsulated secretory
coated
Prior art date
Application number
FI962841A
Other languages
English (en)
Swedish (sv)
Other versions
FI962841A (fi
FI118853B (fi
Inventor
Kanti Jain
Albert L Rubin
Original Assignee
Rogosin Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rogosin Inst filed Critical Rogosin Inst
Publication of FI962841A0 publication Critical patent/FI962841A0/fi
Publication of FI962841A publication Critical patent/FI962841A/fi
Application granted granted Critical
Publication of FI118853B publication Critical patent/FI118853B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/39—Pancreas; Islets of Langerhans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/04—Enzymes or microbial cells immobilised on or in an organic carrier entrapped within the carrier, e.g. gel or hollow fibres
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0012—Cell encapsulation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • C12N5/0677—Three-dimensional culture, tissue culture or organ culture; Encapsulated cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/126—Immunoprotecting barriers, e.g. jackets, diffusion chambers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/54—Collagen; Gelatin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/70—Polysaccharides
    • C12N2533/76—Agarose, agar-agar

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • Dispersion Chemistry (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Nutrition Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI962841A 1994-01-13 1996-07-12 Makrokapseloituja erittäviä soluja FI118853B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US18126994A 1994-01-13 1994-01-13
US18126994 1994-01-13
PCT/US1995/000400 WO1995019430A1 (en) 1994-01-13 1995-01-12 Macroencapsulated secretory cells
US9500400 1995-01-12

Publications (3)

Publication Number Publication Date
FI962841A0 true FI962841A0 (fi) 1996-07-12
FI962841A FI962841A (fi) 1996-09-12
FI118853B FI118853B (fi) 2008-04-15

Family

ID=22663563

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962841A FI118853B (fi) 1994-01-13 1996-07-12 Makrokapseloituja erittäviä soluja

Country Status (19)

Country Link
US (3) US5643569A (fi)
EP (3) EP1418228B1 (fi)
JP (4) JP3948742B2 (fi)
KR (1) KR100474803B1 (fi)
CN (1) CN1087779C (fi)
AT (3) ATE275194T1 (fi)
AU (1) AU681240C (fi)
CA (1) CA2181156C (fi)
DE (3) DE69534865T2 (fi)
DK (2) DK1418228T3 (fi)
ES (3) ES2260568T3 (fi)
FI (1) FI118853B (fi)
HK (1) HK1084693A1 (fi)
IL (1) IL112330A (fi)
NO (2) NO323228B1 (fi)
NZ (3) NZ278809A (fi)
PT (3) PT1418228E (fi)
RU (2) RU2177503C2 (fi)
WO (1) WO1995019430A1 (fi)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834005A (en) * 1992-02-24 1998-11-10 Encelle, Inc. Bioartificial devices and cellular matrices therefor
US5830492A (en) * 1992-02-24 1998-11-03 Encelle, Inc. Bioartificial devices and cellular matrices therefor
US5824331A (en) * 1992-02-24 1998-10-20 Encelle, Inc. Bioartificial devices and cellular matrices therefor
US6231881B1 (en) 1992-02-24 2001-05-15 Anton-Lewis Usala Medium and matrix for long-term proliferation of cells
RU2177503C2 (ru) * 1994-01-13 2001-12-27 Рогозин Институт Макрогранула с секреторными клетками, способ ее получения и способ лечения заболеваний, вызванных нарушением функционирования секреторных клеток
USRE39542E1 (en) * 1994-01-13 2007-04-03 The Rogosin Institute Preparation of agarose coated, solid agarose-collagen beads containing secretory cells
US5916790A (en) * 1995-03-03 1999-06-29 Metabolex, Inc. Encapsulation compositions, and methods
AU705108B2 (en) * 1995-03-03 1999-05-13 Metabolex, Inc. Novel encapsulation process by a gelling polymer
US5965125A (en) 1995-10-25 1999-10-12 Transkaryotic Therapies, Inc. Hybrid matrix implants and explants
US6419920B1 (en) 1995-10-25 2002-07-16 Trans Karyotic Therapies, Inc. Hybrid matrix implants and explants
EP0822857A1 (en) * 1996-02-23 1998-02-11 Circe Biomedical, Inc. Novel artificial pancreas
US7297331B2 (en) 1996-04-03 2007-11-20 The Rogosin Institute Beads containing restricted cancer cells producing material suppressing cancer cell proliferation
KR100477296B1 (ko) * 1996-04-03 2005-05-16 더 로고신 인스티튜트 확산성의생물학적산물생산세포를함유하는이식가능한아가로오스-콜라겐비드,및그의용도
ATE250858T1 (de) * 1996-04-03 2003-10-15 Rogosin Inst Implantierbare agarose-kollagenkügelchen enthaltende zellen, die ein diffusionsfähiges biologisches produkt bilden und ihre verwendung
US6303151B1 (en) * 1996-04-03 2001-10-16 The Rogosin Institute Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment
US5888497A (en) * 1996-04-03 1999-03-30 The Rogosin Institute Agarose coated agarose beads containing cancer cells that produce material which suppresses cancer cell proliferation
US6224912B1 (en) * 1996-04-03 2001-05-01 The Rogo Institute Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment
RU2179034C2 (ru) 1996-09-13 2002-02-10 Транскариотик Терапиз, Инк. ЛЕЧЕНИЕ В СЛУЧАЕ ДЕФИЦИТА α-ГАЛАКТОЗИДАЗЫ А
AU8577498A (en) * 1997-07-22 1999-02-16 General Hospital Corporation, The Modulation of multicellular aggregates by solid stress
US5922339A (en) * 1998-01-27 1999-07-13 Usala; Anton-Lewis Compositions and methods for biocompatible implants
US6303355B1 (en) 1999-03-22 2001-10-16 Duke University Method of culturing, cryopreserving and encapsulating pancreatic islet cells
US6365385B1 (en) * 1999-03-22 2002-04-02 Duke University Methods of culturing and encapsulating pancreatic islet cells
US6391576B1 (en) * 1999-10-13 2002-05-21 Japan Bioindustry Association Method for isolating a microbe
US6279656B1 (en) 1999-11-03 2001-08-28 Santrol, Inc. Downhole chemical delivery system for oil and gas wells
US7700660B2 (en) 2000-05-31 2010-04-20 Encelle, Inc. Method of treating chronic ulcers
CA2450650C (en) * 2002-12-24 2007-08-28 An-Go-Gen Inc. Encapsulated cell therapy
WO2004075855A2 (en) * 2003-02-26 2004-09-10 Biomed Solutions, Llc Process for in vivo treatment of specific biological targets in bodily fluid
US20050053586A1 (en) 2003-09-04 2005-03-10 Bryan Conn Entrapped stem cells and uses thereof
WO2006053052A2 (en) * 2004-11-11 2006-05-18 The Rogosin Institute Method for treating patients with implants of islets which have been kept in long term, in vitro culture
PT1928249E (pt) * 2005-09-26 2012-05-25 Rogosin Inst Inc Macrocontas contendo células secretoras compreendendo agarose seakem gold e utilizações destas
US20070116680A1 (en) * 2005-11-18 2007-05-24 Rensselaer Polytechnic Institute Stem cells within gel microenvironments
EP2029727B1 (en) 2006-06-16 2012-04-11 FMC Biopolymer AS Alginate coated, collagen matrix cellular device, preparative methods, and uses thereof.
JP2010516273A (ja) * 2007-01-24 2010-05-20 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ 培養細胞を処理する方法
CA2698212A1 (en) 2007-08-23 2009-02-26 Intrexon Corporation Methods and compositions for diagnosing disease
CN101868241A (zh) * 2007-09-28 2010-10-20 英特瑞克斯顿股份有限公司 表达生物治疗分子的治疗基因开关构建物和生物反应器以及它们的应用
DE102010040687A1 (de) 2010-09-14 2012-03-15 Hamilton Bonaduz Ag Verfahren zum Herstellen von Wirkstoff-Beads
US10655120B2 (en) 2011-03-21 2020-05-19 The University Of Newcastle Upon Tyne Transport of cells in hydrogels
DE102011050024A1 (de) 2011-04-29 2012-10-31 Hamilton Bonaduz Ag Analysevorrichtung für eine berührungslose Analyse der Ausformung eines transparenten Körpers und Verfahren zur Durchführung der berührungslosen Analyse
PT2809782T (pt) * 2012-01-31 2017-12-01 The Rogosin Inst Inc Método melhorado para o fabrico de macro esferas
KR101327630B1 (ko) * 2012-03-05 2013-11-13 울산대학교 산학협력단 아텔로콜라겐을 이용한 췌도세포 이식용 담체의 제조방법 그리고 이를 이용하여 제조된 인공췌장
UY38389A (es) 2018-09-27 2020-04-30 Sigilon Therapeutics Inc Dispositivos implantables para terapia celular y métodos relacionados
WO2024081309A1 (en) 2022-10-11 2024-04-18 Sigilon Therapeutics, Inc. Engineered cells and implantable elements for treatment of disease
WO2024081310A1 (en) 2022-10-11 2024-04-18 Sigilon Therapeutics, Inc. Engineered cells and implantable elements for treatment of disease

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352883A (en) * 1979-03-28 1982-10-05 Damon Corporation Encapsulation of biological material
US4391909A (en) * 1979-03-28 1983-07-05 Damon Corporation Microcapsules containing viable tissue cells
US4409331A (en) * 1979-03-28 1983-10-11 Damon Corporation Preparation of substances with encapsulated cells
SE441009B (sv) * 1982-03-08 1985-09-02 Kjell Nilsson Sett att immobilisera levande biomaterial i perlformiga polymerer
US4798786A (en) * 1982-05-06 1989-01-17 Stolle Research And Development Corporation Living cells encapsulated in crosslinked protein
CA1196862A (en) * 1983-06-01 1985-11-19 Anthony M.F. Sun Microencapsulation of living tissue and cells
US4663286A (en) * 1984-02-13 1987-05-05 Damon Biotech, Inc. Encapsulation of materials
US4997443A (en) * 1985-08-26 1991-03-05 Hana Biologics, Inc. Transplantable artificial tissue and process
US4902295A (en) * 1985-08-26 1990-02-20 Hana Biologics, Inc. Transplantable artificial tissue
SE8604684L (sv) * 1986-11-03 1988-05-04 Excorim Kommanditbolag Sett att belegga fasta partiklar med en hydrofil gel samt genom settet belagda partiklar
US5053332A (en) * 1989-07-24 1991-10-01 Cook Richard B Agarose beads, preferably incorporating biological materials
US5227298A (en) * 1990-08-17 1993-07-13 The Trustees Of Columbia University In The City Of New York Method for microencapuslation of cells or tissue
FR2686250A1 (fr) * 1992-01-16 1993-07-23 Coletica Compositions injectables contenant en suspension des microcapsules a base de collagene, leur utilisation biomedicale et des compositions pharmaceutiques.
WO1993024076A1 (en) * 1992-05-29 1993-12-09 The Regents Of The University Of California Coated transplant and method for making same
AU5728994A (en) * 1992-11-24 1994-06-22 Clover Consolidated, Limited Cytoprotective, biocompatible, retrievable macrocapsules
RU2177503C2 (ru) * 1994-01-13 2001-12-27 Рогозин Институт Макрогранула с секреторными клетками, способ ее получения и способ лечения заболеваний, вызванных нарушением функционирования секреторных клеток
US5888497A (en) * 1996-04-03 1999-03-30 The Rogosin Institute Agarose coated agarose beads containing cancer cells that produce material which suppresses cancer cell proliferation
US6224912B1 (en) * 1996-04-03 2001-05-01 The Rogo Institute Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment

Also Published As

Publication number Publication date
EP0742818A4 (en) 2002-01-09
FI962841A (fi) 1996-09-12
JP3989492B2 (ja) 2007-10-10
EP1666585A1 (en) 2006-06-07
PT1666585E (pt) 2008-12-10
NO323228B1 (no) 2007-02-05
JP2005137376A (ja) 2005-06-02
DE69534865D1 (de) 2006-05-11
WO1995019430A1 (en) 1995-07-20
RU2177503C2 (ru) 2001-12-27
US5643569A (en) 1997-07-01
KR100474803B1 (ko) 2005-03-10
USRE40555E1 (en) 2008-10-28
AU681240B2 (en) 1997-08-21
NZ329619A (en) 1999-09-29
RU2208636C2 (ru) 2003-07-20
ATE408005T1 (de) 2008-09-15
IL112330A0 (en) 1995-03-30
IL112330A (en) 1999-01-26
PT1418228E (pt) 2006-09-29
ES2227544T3 (es) 2005-04-01
PT742818E (pt) 2004-12-31
HK1084693A1 (en) 2006-08-04
EP0742818A1 (en) 1996-11-20
DE69533437T2 (de) 2005-09-15
JP3948742B2 (ja) 2007-07-25
ATE320482T1 (de) 2006-04-15
USRE38027E1 (en) 2003-03-11
JPH09510868A (ja) 1997-11-04
DK1666585T3 (da) 2009-01-12
CN1141650A (zh) 1997-01-29
JP2007020585A (ja) 2007-02-01
EP1418228B1 (en) 2006-03-15
JP2006345875A (ja) 2006-12-28
AU681240C (en) 2006-12-07
CA2181156C (en) 2001-10-16
NO324570B1 (no) 2007-11-26
CN1087779C (zh) 2002-07-17
DE69534865T2 (de) 2006-08-17
ATE275194T1 (de) 2004-09-15
ES2260568T3 (es) 2006-11-01
KR20050005235A (ko) 2005-01-13
NO962955D0 (no) 1996-07-15
NO20051359L (no) 1996-09-11
EP1666585B1 (en) 2008-09-10
DE69533437D1 (de) 2004-10-07
MX9602765A (es) 1998-06-30
EP0742818B1 (en) 2004-09-01
NZ509363A (en) 2006-02-24
JP4435134B2 (ja) 2010-03-17
DE69535842D1 (de) 2008-10-23
ES2309849T3 (es) 2008-12-16
NZ278809A (en) 1998-03-25
AU1526795A (en) 1995-08-01
FI118853B (fi) 2008-04-15
CA2181156A1 (en) 1995-07-20
DK1418228T3 (da) 2006-07-17
EP1418228A1 (en) 2004-05-12
NO962955L (no) 1996-09-11

Similar Documents

Publication Publication Date Title
FI962841A (fi) Makrokapseloituja erittäviä soluja
DE69526601D1 (de) Leistungsfaktorkorrektur-Vorkompensierungsschaltung
NO995180L (no) Effektregulering i radiosambandsnett, saerlig av kategori CDMA
FI960631A (fi) Termostabiilit ksylanaasit
DE69525441D1 (de) Leistungsfaktorkorrektur
DE69522335D1 (de) Klasse-BC Leistungsverstärker für AM-FM Sender
NO910312D0 (no) Fremgangsmaate til fremstilling av elektroder for elektrokjemiske celler.
NO861174L (no) Fralandsplattform og fremgangsmaate ved installering av samme.
BR9607041A (pt) Célula eletroquímica primário
DK0954903T3 (da) Fremgangsmåde til regulering af effektforstærkningen
DE59510269D1 (de) Leistungs-Halbleiterbauelement
DK0742818T3 (da) Makroindkapslede sekretoriske celler
NO912123L (no) Stroemtilfoerselsleder for en elektrode.
KR960025010U (ko) 전원단의 누설 억제용 관통콘덴서 구조
KR960008703U (ko) 전자렌지의 출력 조절장치
KR960025430U (ko) 스테이지 경사 보상이 가능한 웨이퍼 척 장치
KR970055540U (ko) 가습기
FI945329A0 (fi) Testanlaeggning foer en basstation i en utvidgad cell
DK403283A (da) Fremgangsmaade til montering af plejlstangs/krumtap-gruppen i hermetiske kompressorer
KR970006225U (ko) 양측전원 단자를 구비한 환풍기
KR960002458U (ko) 가습기 겸용 전기난로
KR950031467U (ko) 이온 주입 조절장치
NO961415D0 (no) Elektrolyttforsterker
KR960002455U (ko) 전자렌지의 출력 조절장치
KR950034649U (ko) 음성레벨을 이용한 전원 차단회로

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 118853

Country of ref document: FI

MA Patent expired